Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganmao Kesou Keli is a traditional Chinese medicine (TCM) granule developed by Beijing Yushengtang Pharmaceutical Co., Ltd. for the treatment of the common cold and associated cough. The formulation is a complex mixture of herbal extracts, including Bupleurum, Pueraria, Scutellaria, and Lonicera, which collectively provide antipyretic, anti-inflammatory, and antitussive effects. It is indicated for symptoms such as fever, headache, cough, and sore throat. The medicine works by 'relieving the exterior' (a TCM concept for treating early-stage infections), clearing internal heat, and facilitating the expulsion of phlegm. It is an orally administered product that has received regulatory approval in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ganmao kesou keli.